These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36031783)

  • 1. The Effect of Denosumab and Risk Factors for Recurrence in Spinal Giant Cell Tumors: A Systematic Review and Meta-Analysis.
    Noh SH; Ha Y; Cho PG; Kim KN; Shin DA; Kim SH
    Yonsei Med J; 2022 Sep; 63(9):834-841. PubMed ID: 36031783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature.
    Al Farii H; McChesney G; Patel SS; Rhines LD; Lewis VO; Bird JE
    Spine J; 2024 Jun; 24(6):1056-1064. PubMed ID: 38301904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
    Agarwal MG; Gundavda MK; Gupta R; Reddy R
    Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
    Scoccianti G; Totti F; Scorianz M; Baldi G; Roselli G; Beltrami G; Franchi A; Capanna R; Campanacci DA
    Clin Orthop Relat Res; 2018 Sep; 476(9):1783-1790. PubMed ID: 30778015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture.
    Medellin MR; Fujiwara T; Tillman RM; Jeys LM; Gregory J; Stevenson JD; Parry M; Abudu A
    Bone Joint J; 2018 Dec; 100-B(12):1626-1632. PubMed ID: 30499317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between preoperative denosumab and the risk of local recurrence in patients with giant cell tumor of bone: A meta-analysis and systematic review.
    Sun Z; Wu Z; Zhang L; Jia Q; Zhou Z; Xiao J
    J Cancer Res Ther; 2023 Feb; 19(1):25-33. PubMed ID: 37006039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denosumab salvage therapy in an 11-year-old boy with locally recurrent unresectable giant cell tumor of the lumbar spine after surgery.
    Luo Y; Xiu P; Chen H; Zeng J; Song Y; Li T
    Neurochirurgie; 2023 May; 69(3):101427. PubMed ID: 36828057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-operative denosumab is associated with higher risk of local recurrence in giant cell tumor of bone: a systematic review and meta-analysis.
    Chen X; Li H; Zhu S; Wang Y; Qian W
    BMC Musculoskelet Disord; 2020 Apr; 21(1):256. PubMed ID: 32312263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection and reconstruction with and without neoadjuvant denosumab in campanacci grade III giant cell tumors of proximal humerus: a retrospective comparative study.
    Sahito B; Ali SME; Farooqui SF; Abro A; Ahmed J; Younis
    Eur J Orthop Surg Traumatol; 2023 Jan; 33(1):81-88. PubMed ID: 34773494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases.
    Deveci MA; Paydaş S; Gönlüşen G; Özkan C; Biçer ÖS; Tekin M
    Acta Orthop Traumatol Turc; 2017 Jan; 51(1):1-6. PubMed ID: 27784623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of denosumab before resection and reconstruction in giant cell tumors of bone: a single-centered retrospective cohort study.
    Sahito B; Ali SME; Kumar D; Kumar J; Hussain N; Lakho T
    Eur J Orthop Surg Traumatol; 2022 Apr; 32(3):567-574. PubMed ID: 34050817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the Bone: A Systematic Review and Meta-Analysis.
    Yayan J
    Cancer Control; 2020; 27(3):1073274820934822. PubMed ID: 32869648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for recurrence of giant cell tumours of bone.
    Siddiqui MA; Seng C; Tan MH
    J Orthop Surg (Hong Kong); 2014 Apr; 22(1):108-10. PubMed ID: 24781627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
    Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
    Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive Giant Cell Tumor of the Lateral Skull Base: A Systematic Review, Meta-Analysis, and Case Illustration.
    Freeman JL; Oushy S; Schowinsky J; Sillau S; Youssef AS
    World Neurosurg; 2016 Dec; 96():47-57. PubMed ID: 27269210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
    Mattei TA; Ramos E; Rehman AA; Shaw A; Patel SR; Mendel E
    Spine J; 2014 Jul; 14(7):e15-21. PubMed ID: 24534393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment progress on giant cell tumors of bone].
    Liang P
    Zhongguo Gu Shang; 2018 Mar; 31(3):292-296. PubMed ID: 29600686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature.
    Luengo-Alonso G; Mellado-Romero M; Shemesh S; Ramos-Pascua L; Pretell-Mazzini J
    Arch Orthop Trauma Surg; 2019 Oct; 139(10):1339-1349. PubMed ID: 30877429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denosumab in the treatment of giant cell tumor of the spine. Preliminary report, review of the literature and protocol proposal.
    Boriani S; Cecchinato R; Cuzzocrea F; Bandiera S; Gambarotti M; Gasbarrini A
    Eur Spine J; 2020 Feb; 29(2):257-271. PubMed ID: 31098716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.